Sensei Biotherapeutics, Inc. (SNSE) Tops Q2 EPS by 1c

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Coty (COTY) Misses Q4 EPS by 1c, offers outlook
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance